Expression of apolipoprotein E inhibits aggregation of the C-terminal fragments of β-amyloid precursor protein

Neuroscience Letters

Volumn 210, Issue 1, 1996, Pages 65-68

  Ohman, Tauni ^a,b   Dang, Nocthao ^a   LeBoeuf, Renee C ^a   Furlong, Clement E ^a   Fukuchi, Ken Ichiro ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

alzheimer's disease; Amyloidogenesis; Amyloidosis; Transfection; Western blot

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; IMMUNOBLOTTING; KIDNEY CELL; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 0030005454     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12663-X     Document Type: Article

References (22)

1. Bailey, N.T.J., Statistical Methods in Biology, 2nd edn., Hodder and Stoughton, London, 1981, pp. 43-51.
2. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
3. Evans, K.C., Berger, E.P., Cho, C.-G. and Weisgraber, K.H., Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease, Proc. Natl. Acad. Sci. USA, 92 (1995) 763-767.
4. Fukuchi, K., Kamino, K., Deeb, S.S., Smith, A.C., Dang, T. and Martin, G.M., Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity, Biochem. Biophys. Res. Commun., 182 (1992) 165-173.
5. Fukuchi, K., Kamino, K., Deeb, S.S., Furlong, C.E., Sundstrom, J.A., Smith, A.C. and Martin, G.M., Expression of a carboxyterminal region of the β-amyloid precursor protein in a heterogeneous culture of neuroblastoma cells: evidence for altered processing and selective neurotoxicity, Mol. Brain Res., 16 (1992) 37-46.
6. Kim, K.S., Miller, D.L., Sapienza, V.J., Chen, C.-M.J., Bai, C., Grundke-Iqbal, I., Currie, J.R. and Wisniewski, H.M., Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide, Neurosci. Res. Commun., 2 (1988) 121-130.
7. LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S. and Frail, D.E., Isoform-specific binding of Apolipoprotein E to β-amyloid, J. Biol. Chem., 269 (1994) 23403-23406.
8. Maruyama, K., Terakado, K., Usami, M. and Yoshikawa, K., Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor, Nature, 347 (1990) 566-569.
9. Mazur-Kolecka, B., Frackowiak, J. and Wisniewski, H.M., Apolipoprotein E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's β-amyloid peptide in cultured vascular smooth muscle cells, Brain Res., 698 (1995) 217-222.
10. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. and Ikeda, K., Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain Res., 541 (1991) 163-166.
11. Näslund, J., Thyberg, J., Tjernberg, L.O., Wernstedt, C., Karlstrom, A.R., Bogdanovic, N., Gandy, S.E., Lannfelt, L., Terenius, L. and Nordstedt, C., Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain, Neuron, 15 (1995) 219-228.
12. Niwa, H., Yamamura, K.-I. and Miyazaki, J.-I., Efficient selection for high-expression transfectants with a novel eukaryotic vector, Gene, 108 (1991) 193-200.
13. Pike, C.J., Overman, M.J., Cotman, C.W., Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro, J. Biol. Chem., 270 (1995) 23895-23898.
14. Sanan, D.A., Weisgraber, K.H., Russel, S.J., Mahley, R.W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., Roses, A.D. and Strittmatter, W.J., Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils, J. Clin. Invest., 94 (1994) 860-869.
15. Saunders, A.M., Schmader, K., Breitner, J.C.S., Benson, M.D., Brown, W.T., Goldfarb, L., Goldgaber, D., Manwaring, M.G., Szymanski, M.H., McCown, N., Dole, K.C., Schmechel, D., Strittmatter, W.J., Pericak-Vance, M. and Roses, A.D., Apolipoprotein E ε4 allele distribution in late onset Alzheimer's disease and in other amyloid forming diseases, Lancet, 342 (1993) 710-711.
16. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.M., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A.D., Association of apolipoprotein E4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43 (1993) 1467-1472.
17. St. Clair, D., Rennie, M., Slorach, E., Norrman, J., Yates, C. and Carothers, A., Apolipoprotein E ε4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers, J. Med. Genet., 32 (1995) 642-644.
18. Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.-M., Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D., Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 8098-8102.
19. Weisgraber, K.H. and Shinto, L.H., Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma: impact on receptor binding activity, J. Biol. Chem., 266 (1991) 12029-12034.
20. Wisniewski, T., Castano, E.M., Golabek, A., Vogel, T. and Frangione, B., Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro, Am. J. Pathol., 145 (1994) 1030-1035.
21. Wisniewski, T., Golabek, A., Kida, E., Wisniewski, K.E. and Frangione, B., Conformational mimicry in Alzheimer's disease: role of apolipoprotein E in amyloidogenesis, Am. J. Pathol., 147 (1995) 238-244.
22. Wisniewski, T., Frackowiak, J. and Mazur-Kolecka, B., In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels, Neurosci. Lett., 183 (1995) 120-123.